PTC
SRPT icon

Private Trust Company’s Sarepta Therapeutics SRPT Stock Holding History

Private Trust Company’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-39
Closed -$667 – 2659
2025
Q2 		$667 Buy
+39
New +$1.66K ﹤0.01% 2405
2025
Q1 		– Sell
-35
Closed -$4.26K – 2539
2024
Q4 		$4.26K Hold
35
– – ﹤0.01% 2030
2024
Q3 		$4.37K Hold
35
– – ﹤0.01% 1992
2024
Q2 		$5.53K Hold
35
– – ﹤0.01% 1892
2024
Q1 		$4.53K Hold
35
– – ﹤0.01% 1957
2023
Q4 		$3.38K Hold
35
– – ﹤0.01% 2036
2023
Q3 		$4.24K Hold
35
– – ﹤0.01% 1930
2023
Q2 		$4.01K Buy
+35
New +$4.51K ﹤0.01% 1944
2022
Q4 		– Sell
-2
Closed – – 2267
2022
Q3 		$0 Hold
2
– – ﹤0.01% 2188
2022
Q2 		$0 Buy
+2
New +$147 ﹤0.01% 2139

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Private Trust Company's SRPT Position: Q3 2025 in Review

Private Trust Company sold out of Sarepta Therapeutics (SRPT) in Q3 2025, closing a stake of 39 shares — an estimated $667 sold.

Private Trust Company first reported a position in SRPT in Q2 2022 and held it in 10 quarters. The position peaked at $5.53K in Q2 2024. 319 funds tracked by Wall St. Rank hold SRPT as of Q3 2025.

  • Private Trust Company reported no remaining Sarepta Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Private Trust Company sold 39 Sarepta Therapeutics shares in Q3 2025, an estimated $667.
  • Private Trust Company first reported a position in Sarepta Therapeutics in Q2 2022 and held it in 10 quarters.
  • Private Trust Company's Sarepta Therapeutics position peaked at $5.53K in Q2 2024.
  • 319 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2025.

Based on Private Trust Company's 13F filing for Q3 2025, filed 15 Oct 2025.